PA Criteria · Patient Intake · Readiness Score · Appeals · P2P · Post-Approval

Stop guessing.
Get approved.

Select your drug, payer, and state. PathToApproval walks your office through every step — from benefits investigation through post-approval monitoring.

Request Access See how it works
Currently Available
eplontersen (Wainua)
AstraZeneca · hATTR-PN
vutrisiran (Amvuttra)
Alnylam · hATTR-PN + ATTR-CM
acoramidis (Attruby)
BridgeBio Pharma · ATTR-CM
14
Workflow Modules
3
Live Drug Modules
6
States — CT, NY + 4 coming
100%
Public Data Sources
Platform Features
Everything your office needs before a PA is submitted.
🩺
Patient Intake & Readiness Score
Enter clinical data only — no patient identifiers. PathToApproval scores readiness, identifies blockers, and generates a personalized action plan before you submit a single form.
🔍
Benefits Investigation Playbook
Select the patient's plan and get the exact call script, submission route, and red flags for that specific payer. No guessing which number to call or what to ask.
⚖️
Denial Pathway Intelligence
A complete five-step escalation ladder from step therapy override through external independent review — including the state law protections most offices never know exist.
✍️
AI-Personalized Appeal Letters
Seven document types drafted by AI based on the patient's specific profile — medical necessity, peer-to-peer prep memos, step therapy override letters, and more.
🔄
Reauthorization Workflow
Month-by-month timeline, required documentation checklist, and baseline tracking guide to protect against therapy gaps at the 12-month renewal.
💰
Affordability & Patient Support
Every savings program, independent foundation, and patient support resource — with eligibility criteria and enrollment contacts in one place.
Who It's For
Built for rare disease office staff.

Prior authorization for rare disease therapeutics is uniquely complex — multiple payer types, evolving criteria, high denial rates. PathToApproval was built by someone who works in this space every day.

Neurology and cardiology rare disease physician offices
Prior authorization coordinators and office managers
Practices managing hATTR-PN, ATTR-CM, and expanding rare disease portfolios
Offices working across multiple payer types and states simultaneously
State Coverage
CT + NY live. New England expansion underway.
CT
Connecticut
Live
NY
New York
Live
MA
Massachusetts
Coming Soon
VT
Vermont
Coming Soon
NH
New Hampshire
Coming Soon
ME
Maine
Coming Soon
Payer Coverage
Live payers. Expanding continuously.
Aetna Commercial
Medicare Part B (FFS)
UnitedHealthcare
Cigna Commercial
CT Medicaid — HUSKY
NY Medicaid — eMedNY
Humana — coming soon
BCBS — coming soon
EmblemHealth — coming soon
Aetna Medicare Advantage — coming soon